This is the annual report of the NBA for the 2011-12 financial year. It also includes the NBA Board annual report for the same period.
Presents a high level view of the sector, its stakeholders and the blood products used, and describes the NBA's objectives.
Identifies key statistics and major achievements during the year, and presents reports of the NBA's General Manager and the NBA Board.
In the context of the NBA's outcome and program structure, summarises the NBA's performance against the key performance indicators and qualitative and quantitative deliverables established in the 2011-12 Portfolio Budget Statements, and reports on how the NBA manages the supply of blood and blood products through the development and maintenance of the National Supply Plan and Budget, the management of contracts with suppliers and on progress in developing methodologies for assessing new products.
Summarises the NBA's outcome and program structure and reports on the NBA's performance against the key performance indicators and qualitative and quantitative deliverables established in the 2011-12 Portfolio Budget Statements, with particular reference to initiatives to improve the performance of the blood sector and manage risks associated with the supply and administration of blood products.
Summarises the NBA's outcome and program structure and reports on the NBA's performance against the key performance indicators and qualitative and quantitative deliverables established in the 2011-12 Portfolio Budget Statements to assist the sector to comply with standards to support the safe, high quality management and use of blood and blood products and services.
Includes information on corporate governance, planning and service delivery, people management, audit arrangements and how we manage risk and fraud.
Discusses the NBA's budget, financial and asset management and purchasing arrangements, and presents the audited financial statements.
Contains additional information to further explain material in the body of the report such as governments' objectives under the National Blood Agreement, the NBA's agency resource statement, further information about NBA stakeholders, lists of blood and blood products supplied under contract, biographies of NBA Board Members, further information about fresh blood supply by state and territory, mandatory reporting on several government policies, errata, acronyms and a glossary of terms, and a list of requirements.